Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12615001324505
ACTRN12615001324505
Completed
Phase 1

In patients with prostate cancer, what is the uptake in tumours and normal tissue on positron emission tomography (PET) following administration of Ga-68 THP-PSMA?

Peter MacCallum Cancer Centre0 sites14 target enrollmentDecember 3, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsprostate cancerCancer - Prostate

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
prostate cancer
Sponsor
Peter MacCallum Cancer Centre
Enrollment
14
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 3, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Peter MacCallum Cancer Centre

Eligibility Criteria

Inclusion Criteria

  • •1\.Age 18 – 80 years
  • •2\.Proven adenocarcinoma of the prostate gland.
  • •3\.All patients have to be suitable for surgical treatment as part of their normal management
  • •4\.Able to comply with treatment plans, scheduled visits, all study PET imaging and follow\-up

Exclusion Criteria

  • •1\.Any prior treatment for the prostate gland tumours

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
PROCOG: Investigating Cognitive Problems in Men with Prostate CancerProstate CancerCognitive problemsCancer - ProstateMental Health - Studies of normal psychology, cognitive function and behaviourMental Health - AnxietyMental Health - DepressionMental Health - Other mental health disorders
ACTRN12621001608853Macquarie University150
Completed
Not Applicable
The Body concept of prostate carcinoma patientsC61Malignant neoplasm of prostate
DRKS00003319Martin-Luther-Universität Halle WittenbergInstitut für Gesundheits- und Pflegewissenschaft339
Recruiting
Not Applicable
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancer
JPRN-UMIN000019278Kyoto University2,000
Recruiting
Not Applicable
The *Utrecht Prostate Cohort for cancer treatment intervention studies and long term evaluation (UPC)* studyProstate cancer1003859710018188
NL-OMON50026niversitair Medisch Centrum Utrecht5,000
Recruiting
Phase 1
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 TrialProstate cancerTherapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2022-501551-90-00Gasthuiszusters Antwerpen493